Bucharest Emergency University Hospital
Bucharest 050098
0 studies enrolling now · 2 studies all time
What they study most
Atrial Fibrillation, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Studies at this site
- Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. — Completed
- Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed